Epigenetic silencing of chemokine CCL2 represses macrophage infiltration to potentiate tumor development in small cell lung cancer
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 499, 148-163
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology of Jilin Province
- National Key Basic Research Program For Youth
- National Natural Science Foundation of China
- Department of Finance of Jilin Province
This publication has 56 references indexed in Scilit:
- Genomic Deregulation of the E2F/Rb Pathway Leads to Activation of the Oncogene EZH2 in Small Cell Lung CancerPLOS ONE, 2013
- Macrophage plasticity and polarization: in vivo veritasJournal of Clinical Investigation, 2012
- The role of EZH2 in tumour progressionBritish Journal of Cancer, 2011
- The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSFNature Immunology, 2011
- Inhibitory B7-family molecules in the tumour microenvironmentNature Reviews Immunology, 2008
- Cooperation between EZH2, NSPc1-mediated histone H2A ubiquitination and Dnmt1 in HOX gene silencingNucleic Acids Research, 2008
- Macrophages and cancerFrontiers in Bioscience-Landmark, 2008
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005
- Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissuesBlood, 2004
- Alternative activation of macrophagesNature Reviews Immunology, 2003